Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules

AIDS

Volumn 10, Issue 10, 1996, Pages 1075-1083

  Shiga, Hajime ^a   Shioda, Tatsuo ^a   Tomiyama, Hiroko ^a   Takamiya, Yuji ^a   Oka, Shinichi ^a   Kimura, Satoshi ^a   Yamaguchi, Yumi ^b   Gojoubori, Takashi ^b   Rammensee, Hans Georg ^c   Miwa, Kiyoshi ^d   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d AJINOMOTO CO INC   (Japan)

Author keywords

Cytotoxic T lymphocyte epitope; HIV 1; HLA B35; Reverse immunogenetics

Indexed keywords

EPITOPE; HLA B35 ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TARGET CELL; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANTIGEN PRESENTATION; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HIV-1; HLA-B ANTIGENS; HLA-B35 ANTIGEN; HUMANS; MUTATION; OLIGOPEPTIDES; PROTEIN BINDING; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINIA VIRUS;

EID: 9444275373     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yap K, Ada G, Mckenzie I: Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza. Nature 1978, 273:238-239.
2. Lin YL, Askonas BA: Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981, 154:225-234.
3. Lukacher AE, Braciale VL, Brachiale TJ: In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984, 160:814-826.
4. Riddell SR, Watanabe KS, Goodrich JM, Agha ME, Greenberg PD: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992, 257:238-241.
5. Koup R, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome. J Virol 1994, 68:4650-4655.
6. Pantaleo G, Demarest JF, Soudeyns H, et al.: Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994, 370:463-467.
7. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994, 93:1293-1297.
8. Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women: implications for resistance to HIV infection. Nature Med 1995, 1:59-64.
9. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986, 44:959-968.
10. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
11. Guo H-C, Jardetzky TS, Garrett TPJ, Lane WS, Strominger JL, Wiley DC: Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 1992, 360:364-366.
12. Johnson RP, Trocha A, Buchanan TM, Walker BD: Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J Exp Med 1992, 175:961-971.
13. Dai LC, West K, Littaua R, Takahashi K, Ennis FA: Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A-24 restricted cytotoxic T lymphocytes. J Virol 1992, 66:3151-3154.
14. Koenig S, Woods RM, Brewah YA, et al.: Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol 1993, 151:3874-3883.
15. Nixon DF, McMichael AJ: Cytotoxic T-cell recognition to HIV proteins and peptides. AIDS 1991, 5:1049-1059.
16. Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera NB, Moroni M, Zánussi C: HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 1986, ii:1187-1189.
17. Itescu S, Mathru-Wagh U, Skovron ML, et al.: HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 1991,5:37-45.
18. Itescu S, Rose S, Dwyer E, Winchester R: Grouping HLA-B locus specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. Hum Immunol 1995, 42:81-89.
19. Ooba T, Hayashi H, Karaki S, Tanabe M, Kano K, Takiguchi M: The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 1989, 30:76-80.
20. Takamiya Y, Schönbach C, Nokihara K, et al.: HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol 1994, 6:255-261.
21. Takiguchi M, Kawaguchi G, Sekimata M, Hiraiwa M, Kariyone A, Takamiya Y: The role of conserved residues in pockets A and polymorphic residue in pocket E of HLA-B35 in presentation for human minor histocompatibility peptides specific T cells. Int Immunol 1994, 6:1345-1345.
22. Shioda T, Shibuta H: Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 1990, 175:139-148.
23. Falk K, Rötzschke O, Grahovac B, et al.: Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 1993, 38:161-162.
24. Tomiyama H, Takamiya Y, Hill AB, et al.: Isolation of a human allo-peptide presented by HLA-B51 molecules. Int Immunol 1995, 7:905-909.
25. Falk K, Rötzshke O, Takiguchi M, et al.: Peptide motifs of HLA-B51, -B52, and -B78 molecules and implications for Beçhet's disease. Int Immunol 1995, 7:223-228.
26. Culmann B, Gomard E, Kiény MP, et al.: Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 Nef protein. J Immunol 1991, 146:1560-1565.
27. Pamer EG, Harty JT, Bevan MJ, et al.: Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991, 353:852-855.
28. Hill AVS, Elvin J, Willis AC, et al.: Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992, 360:434-439.
29. Nayersina R, Fowler P, Guilhot S, et al.: HLA A2 restricted cytotoxic T lymphocyte response to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993, 150:4659-4671.
30. Kawakami Y, Eliyahu S, Jennings C, et al.: Recognition of multiple epitopes in the human melanoma antigen gp 100 by tumor-infilting T lymphocytes associated with in vivo tumor regression. J Immunol 1995, 154:3961-3968.
31. Phillips RE, Rowland-Jones S, Nixon DF, et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453-459.
32. Engelhard BH: Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 1994, 6:13-23.